Arvinas ARVN
NASDAQ ARVN
$7.50 -0.01 (-0.13%)
At close: Sep 29, 2026 · 4:00 PM EDT

Arvinas (ARVN) EBIT Margin (2017 - 2026)

Updated

Arvinas (ARVN) recorded EBIT Margin of 65.72% in Q2 2026, up 384.92 percentage points from -319.20% a year earlier and up 474.69 percentage points from the prior quarter.

Analysis

Arvinas (ARVN) EBIT Margin (2017 - 2026) Analysis & Trends

On a TTM basis, Arvinas' EBIT Margin came in at -5.72% as of Jun 30, 2026, up 26.10 percentage points year-over-year; for FY2025, it was -45.13%, up 49.86 percentage points from FY2024.

  • Annual EBIT Margin has a five-year change of +421.28 percentage points (FY2020 to FY2025).
  • Across earlier years, EBIT Margin came in at -94.99% in FY2024 (+416.48 pp), -511.46% in FY2023 (-311.16 pp), -200.30% in FY2022 (+151.19 pp) and -351.49% in FY2021 (+114.92 pp).
  • The Q2 2026 figure is the highest quarterly EBIT Margin in data going back to Q1 2017.
  • On a year-over-year basis, EBIT Margin rose in three of the last seven quarters, with an average year-over-year change of -75.50 percentage points.
  • Peak year-over-year performance for EBIT Margin in the last five years was a gain of 748.96 percentage points in Q2 2022, against a drop of 686.95 percentage points in Q4 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at -408.97% (Q1 2026), -785.26% (Q4 2025) and -104.53% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Arvinas 490.40 Mn -2.17 Bn - 65.72%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 65.72%
Mar 31, 2026 -408.97%
Dec 31, 2025 -785.26%
Sep 30, 2025 -104.53%
Jun 30, 2025 -319.20%
Mar 31, 2025 37.82%
Dec 31, 2024 -98.31%
Sep 30, 2024 -58.89%
Jun 30, 2024 -63.40%
Mar 31, 2024 -329.25%
Sep 30, 2023 -213.58%
Jun 30, 2023 -136.88%
Mar 31, 2023 -269.85%
Dec 31, 2022 -200.00%
Sep 30, 2022 -193.67%
Jun 30, 2022 -194.67%
Mar 31, 2022 -217.74%
Dec 31, 2021 -143.07%
Sep 30, 2021 -508.60%
Jun 30, 2021 -943.64%
API Access

Arvinas EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=ARVN&period=max&api_key=YOUR_API_KEY